Back
Photocure ASA Vs. BridgeBio Pharma, Inc. Industry Stock Comparison
Sell
48
PHCUF
Photocure ASA
Last Price:
$7.07
Seasonality Move:
2.93%
Buy
51
BBIO
BridgeBio Pharma, Inc.
Last Price:
$73.17
Seasonality Move:
5.25%
Sell
48
Photocure ASA (PHCUF)
is a Sell
Is Photocure ASA a Buy, Sell or Hold?
-
The current Photocure ASA [PHCUF] share price is $7.07. The Score for PHCUF is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
PHCUF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
51
BridgeBio Pharma, Inc. (BBIO)
is a Buy
Is BridgeBio Pharma, Inc. a Buy, Sell or Hold?
-
The current BridgeBio Pharma, Inc. [BBIO] share price is $73.15. The Score for BBIO is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
-
BBIO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PHCUF Stock Price Chart
What is Photocure ASA's stock price today?
-
The Photocure ASA share price today is $7.07Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PHCUF is experiencing slight buying pressure.
BBIO Stock Price Chart
What is BridgeBio Pharma, Inc.'s stock price today?
-
The BridgeBio Pharma, Inc. share price today is $73.15Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BBIO is experiencing slight selling pressure.
PHCUF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.86 | Buy |
| Relative Strength Index (14 RSI): | 99.93 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.01 - 7.07) | Buy |
| Bollinger Bands (100): | (5.85 - 7.21) | Buy |
BBIO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.66 | Buy |
| Relative Strength Index (14 RSI): | 55.21 | Buy |
| Chaikin Money Flow: | -128497 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (66.58 - 72.4) | Buy |
| Bollinger Bands (100): | (67.73 - 76.59) | Buy |
PHCUF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.07 | Sell |
| 20-day SMA: | 7.06 | Buy |
| 50-day SMA: | 7.02 | Buy |
| 200-day SMA: | 6.12 | Buy |
| 8-day EMA: | 6.72 | Buy |
| 20-day EMA: | 4.94 | Buy |
| 50-day EMA: | 2.7 | Buy |
| 200-day EMA: | 0.8 | Buy |
BBIO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 71.71 | Buy |
| 20-day SMA: | 70.4 | Buy |
| 50-day SMA: | 71.53 | Buy |
| 200-day SMA: | 61.39 | Buy |
| 8-day EMA: | 72.08 | Buy |
| 20-day EMA: | 70.93 | Buy |
| 50-day EMA: | 70.94 | Buy |
| 200-day EMA: | 62.01 | Buy |
Photocure ASA Earnings Growth & PHCUF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
BridgeBio Pharma, Inc. Earnings Growth & BBIO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.27 per share, an increase next quarter of $0.26 per share, an increase this year of $1.05 per share, and an increase next year of $2.15 per share.
Photocure ASA Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
BridgeBio Pharma, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||